4Laekeman, G, Zwaenepoel, L, Reyntens, Jet al. Osteoporosis after combined use of a neuroleptic and antidepressants [ J ]. Pharmacy world and science, 2008, 30(5):613.
5Naidoo U, C-off DC, Klibanski A, et al. Hyperprolactinemia and bone mineral density: the potential impact of antipsychot-ic agents [ J An International Journal, 2003, 28(Suppl/2) : 97.
6Zhang JH,Seeman MV. Antipsyehotic drugs, menstrual reg- ularity and osteoporosis risk[J ]. Archives of women's mental health, 2002, 5(3):93.
7Besnard I, Auclair V, Callers" G, et al. Antipsychotic- drug -induced hyperprolactinemia: physiopathology, clinical fea- tures and guidance[J]. Encephale, 2014, 40(1): 86.
